UBS Group’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $169M | Buy |
1,433,166
+358,083
| +33% | +$41.3M | 0.02% | 766 |
|
|
2026
Q1 | $128M | Sell |
1,075,083
-122,952
| -10% | -$16.1M | 0.02% | 862 |
|
|
2025
Q4 | $163M | Buy |
1,198,035
+32,744
| +3% | +$4.71M | 0.03% | 681 |
|
|
2025
Q3 | $172M | Buy |
1,165,291
+156,533
| +16% | +$21.7M | 0.03% | 667 |
|
|
2025
Q2 | $130M | Sell |
1,008,758
-831,438
| -45% | -$101M | 0.02% | 781 |
|
|
2025
Q1 | $220M | Sell |
1,840,196
-182,143
| -9% | -$22.6M | 0.04% | 459 |
|
|
2024
Q4 | $235M | Buy |
2,022,339
+1,147,481
| +131% | +$145M | 0.04% | 430 |
|
|
2024
Q3 | $118M | Buy |
874,858
+144,004
| +20% | +$19.3M | 0.03% | 643 |
|
|
2024
Q2 | $99.1M | Sell |
730,854
-44,259
| -6% | -$6.02M | 0.02% | 655 |
|
|
2024
Q1 | $100M | Buy |
775,113
+127,582
| +20% | +$15.4M | 0.02% | 645 |
|
|
2023
Q4 | $74.1M | Buy |
647,531
+78,686
| +14% | +$7.85M | 0.02% | 737 |
|
|
2023
Q3 | $51.8M | Sell |
568,845
-13,115
| -2% | -$1.35M | 0.02% | 831 |
|
|
2023
Q2 | $65.5M | Buy |
581,960
+372,839
| +178% | +$39.4M | 0.02% | 682 |
|
|
2023
Q1 | $21.9M | Sell |
209,121
-80,109
| -28% | -$8.37M | 0.01% | 1329 |
|
|
2022
Q4 | $32M | Buy |
289,230
+102,338
| +55% | +$10.7M | 0.01% | 1084 |
|
|
2022
Q3 | $16.3M | Sell |
186,892
-108,396
| -37% | -$9.85M | 0.01% | 1415 |
|
|
2022
Q2 | $23.1M | Buy |
295,288
+41,095
| +16% | +$3.39M | 0.01% | 1220 |
|
|
2022
Q1 | $21.7M | Sell |
254,193
-158,418
| -38% | -$15.2M | 0.01% | 1351 |
|
|
2021
Q4 | $49.5M | Buy |
412,611
+35,135
| +9% | +$4.36M | 0.01% | 964 |
|
|
2021
Q3 | $46.7M | Sell |
377,476
-13,840
| -4% | -$1.78M | 0.01% | 904 |
|
|
2021
Q2 | $46.9M | Buy |
391,316
+57,141
| +17% | +$6.53M | 0.02% | 898 |
|
|
2021
Q1 | $35.1M | Sell |
334,175
-20,844
| -6% | -$2.11M | 0.01% | 1056 |
|
|
2020
Q4 | $36.1M | Buy |
355,019
+22,735
| +7% | +$2.14M | 0.01% | 963 |
|
|
2020
Q3 | $28M | Buy |
332,284
+20,754
| +7% | +$1.62M | 0.01% | 961 |
|
|
2020
Q2 | $20.2M | Buy |
311,530
+67,698
| +28% | +$4.47M | 0.01% | 1073 |
|
|
2020
Q1 | $15.9M | Sell |
243,832
-148,089
| -38% | -$11.7M | 0.01% | 1108 |
|
|
2019
Q4 | $30.9M | Buy |
391,921
+39,062
| +11% | +$3.04M | 0.01% | 1067 |
|
|
2019
Q3 | $28.1M | Buy |
352,859
+54,136
| +18% | +$4.25M | 0.01% | 1012 |
|
|
2019
Q2 | $25M | Sell |
298,723
-9,872
| -3% | -$787K | 0.01% | 1053 |
|
|
2019
Q1 | $24.4M | Buy |
308,595
+42,770
| +16% | +$3.12M | 0.01% | 1022 |
|
|
2018
Q4 | $17.7M | Sell |
265,825
-55,592
| -17% | -$3.85M | 0.01% | 1161 |
|
|
2018
Q3 | $25.7M | Buy |
321,417
+25,893
| +9% | +$1.93M | 0.01% | 1046 |
|
|
2018
Q2 | $19.9M | Buy |
295,524
+12,343
| +4% | +$896K | 0.01% | 1178 |
|
|
2018
Q1 | $21.8M | Sell |
283,181
-5,731
| -2% | -$424K | 0.01% | 1099 |
|
|
2017
Q4 | $19.7M | Buy |
288,912
+14,655
| +5% | +$973K | 0.01% | 1207 |
|
|
2017
Q3 | $17.2M | Sell |
274,257
-11,462
| -4% | -$685K | 0.01% | 1204 |
|
|
2017
Q2 | $15.8M | Buy |
285,719
+12,209
| +4% | +$636K | 0.01% | 1188 |
|
|
2017
Q1 | $13.7M | Buy |
273,510
+10,754
| +4% | +$524K | 0.01% | 1264 |
|
|
2016
Q4 | $13M | Buy |
262,756
+19,569
| +8% | +$992K | 0.01% | 1305 |
|
|
2016
Q3 | $12.8M | Buy |
243,187
+12,705
| +6% | +$623K | 0.01% | 1253 |
|
|
2016
Q2 | $10.3M | Sell |
230,482
-43,594
| -16% | -$1.89M | 0.01% | 1361 |
|
|
2016
Q1 | $11.2M | Sell |
274,076
-18,638
| -6% | -$686K | 0.01% | 1252 |
|
|
2015
Q4 | $10.7M | Buy |
292,714
+21,387
| +8% | +$773K | 0.01% | 1364 |
|
|
2015
Q3 | $8.91M | Sell |
271,327
-14,861
| -5% | -$500K | 0.01% | 1472 |
|
|
2015
Q2 | $10.6M | Sell |
286,188
-114,639
| -29% | -$4.17M | 0.01% | 1429 |
|
|
2015
Q1 | $14M | Sell |
400,827
-33,804
| -8% | -$1.19M | 0.01% | 1200 |
|
|
2014
Q4 | $16.5M | Buy |
+434,631
| New | +$15.9M | 0.01% | 1122 |
|
Other funds holding XYL
UBS Group's XYL Position: Q2 2026 in Review
UBS Group increased its Xylem (XYL) stake by 33% in Q2 2026, buying an estimated $41.3M and bringing the position to 1,433,166 shares worth $169M. The position accounts for 0.02% of the portfolio, ranked #766.
UBS Group first reported a position in XYL in Q4 2014 and has held it in 47 quarters since. The position peaked at $235M in Q4 2024. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- UBS Group held 1,433,166 shares of Xylem worth $169M as of Q2 2026.
- UBS Group bought 358,083 Xylem shares in Q2 2026, an estimated $41.3M.
- Xylem made up 0.02% of UBS Group's portfolio in Q2 2026, its #766 holding.
- UBS Group first reported a position in Xylem in Q4 2014 and has held it in 47 quarters since.
- UBS Group's Xylem position peaked at $235M in Q4 2024.
- 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.